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onclusion.— In organic mitral regurgitation RV function depends
ot only on PASP but also on LV remodeling and septal function.
oi:10.1016/j.acvd.2011.03.073
ersistence of abnormal left ventricular systolic function after
n aortic valve replacement for to aortic stenosis
. Feit , E. Donal , B. Lelong , G.-V. Ruggieri , A. Leguerrier
CHU de Rennes, Rennes, France
ackground.— Patients with severe aortic stenosis have impaired
ystolic function, despite a normal LVEF. Global Longitudinal Strain
GLS) is a simple and reproducible measurement of these abnor-
alities of contraction. Measurements of distortion (strain) in the
adial (GRS) and circumferential direction (GCS) are also possible.
bjective.— We want to evaluate the impact of aortic valve replace-
ent for severe symptomatic aortic valve stenosis on themyocardial
unction recovery evaluated according to a dynamic protocol: at
est and during a standardized stress echocardiography.
ethods.— We prospectively studied 22 patients 6months after aor-
ic valve replacement. These patients were treated with the same
ortic valve bioprosthesis (Magna Ease). These patients gave their
nformed consent. They were able to provide a standardized effort
n a tilting table. Rest echocardiography showed normal functioning
f the prosthesis, normal LVEF, without other valvular disease.
esults.— At rest, left ventricular ejection fraction(68.68± 9.16%),
eptal wall end-diastolic thickness (13.23± 2.68%), left ventricu-
ar end-diastolic diameter (50.4± 8.5mm) were measured at the
ame time that the GLS (−17.27± 3.23%). Despite a normal LV EF,
6.36% of patients have a GLS <−17%. The GCS was on average
20.85± 5.16%. 22.7% of patients have a GCS <−17%. Nevertheless
ost patients have normal GRS (44.69± 18.02%). During exercise,
ost patients in our study do not increase LVEF, despite the good
emodynamic performance of the valve prosthesis (mean trans-
ortic gradient at rest was 17.9± 7.52mm Hg, with a mean valve
rea to 1.31± 0.29 cm2 at rest and 1.32± 0.27 cm2 during exercise).
nly 31.8% of patients show an increase in LVEF greater than 5% dur-
ng a planned submaximal effort at 60-watt. The patients should
each a heart rates ∼110± 10/min and exercise should last over
minutes. The GLS does not increase during exercise with a mean
alue to the effort of −18.05± 3.47%. Only 9% of patients show
ncrease of LV longitudinal function during exercise with an increase
n GLS of 5% or more.
onclusion.— After aortic valve replacement for severe aortic
tenosis, abnormal LV systolic function can be objectiﬁed via mea-
urements of the GCS and GLS.
oi:10.1016/j.acvd.2011.03.074
ow-ﬂow low-gradient aortic stenosis: Prognostic impact and
ffect of surgery
. Addaa, C. Mielot a, F. Cransacb, Y. le Dolleya, A. Salema, X.
irphile c, S. Ansaldi a, F. Thunya, P. Réantc, J.-F. Avierinosa, S.
enarda, C. Sportouch-Dukhanb, S. Laﬁttec, E. Donal d, G.
abiba, P. Lancellotti e
CHU La Timone, Marseille, France
CHU Arnaud-de-Villeneuve, Montpellier, France
Hôpital Haut-Lévêque, Bordeaux, France
Hôpital Pontchaillou, Rennes, France
CHU de Liège, Liège, Belgiumackground.— Low-ﬂow low-gradient aortic stenosis with preserved
jection fraction is a recently described entity, but its prognostic
mplication has only been little studied.
i
c
d19th International Congress of Echocardiography
ethods.— Three hundred and sixty-two patients with severe aortic
tenosis, deﬁned by an aortic valve area (AVA)≤ 0.6 cm2/mé, and
VEF≥ 50% were prospectively included. We performed 2D-strain
maging to assess LV systolic function. Global afterload was evalu-
ted by valvulo-arterial impedance (Zva). Four groups were deﬁned
epending on ﬂow and gradient: low ﬂow was deﬁned as a stroke
olume index (SVi)≤ 35mL/m2, and low gradient as a mean gradient
MG)≤ 40mmHg.
esults.— Group 1 (normal ﬂow high gradient) represented the
ajority of our patients (231 patients, 63.5%). Three-year survival
as 87%. Referral rate for surgery was 75%. There was a signiﬁcant
mprovement of survival among the surgery group (88% vs 75% in the
edical group, P = 0.035).
roup 2 (low ﬂow high gradient) represented 46 patients (12.6%).
hree-year survival was excellent: 95% (P = ns vs group 1). Referral
ate for surgery was 76%. There was a signiﬁcant improvement of
urvival among the surgery group (100% vs 76% in the medical group,
= 0.01).
roup 3 (high ﬂow low gradient) represented 57 patients (15.7%).
hree-year survival was good: 85% (P = ns vs group 1). Referral rate
or surgery was 55%. There was a signiﬁcant improvement of sur-
ival among the surgery group (90.6% vs 74.7% in the medical group,
= 0.04).
roup 4 (low ﬂow high gradient) represented 30 patients (8.2%).
hree-year survival was the lowest: 64% (P = 0.04 vs group 2). Refer-
al rate for surgery was 56%. However there was no signiﬁcant
mprovement with surgery (3-year survival 61.6% vs 72.7% in the
edical group, P = 0.93).
onclusion.— Low-ﬂow low-gradient aortic stenosis is a rare dis-
ase, and its prognosis does not seem to be improved by surgery.
owever these data need to be conﬁrmed in further studies.
oi:10.1016/j.acvd.2011.03.075
ong-term follow-up of patients with the carcinoid syndrome
. Mansencal , E. Mitry , P. Rougier , O. Dubourg
Hôpital Ambroise-Paré, Boulogne, France
ackground.— Carcinoid heart disease (CHD) may occur in patients
resenting with carcinoid tumor and carcinoid syndrome. Stud-
es evaluating the echocardiographic follow-up of these patients
emain rare. The aim of this prospective study was to assess the
rogression of CHD.
ethods.— We studied 90 consecutive patients presenting with
arcinoid tumor and carcinoid syndrome. All patients underwent
nnual transthoracic echocardiographic studies and biological car-
inoid markers. We used a previous validated score of CHD
everity.
esults.— At baseline, prevalence of right- and left-sided CHD was
2% and 8%, respectively, whereas at the end of follow-up (mean
U: 38months), this prevalence was respectively 52% and 20%.
orrelations were strong between urinary 5-HIAA and CHD score
r = 0.86, P < 0.0001). All patients with at least 3 years of carci-
oid syndrome and increased level of urinary 5-HIAA presented with
chocardiographic evidence of CHD. Interestingly, after 3 years of
chocardiographic follow-up of treated patients with carcinoid syn-
rome but without CHD, no patients developed CHD.
onclusion.— Prevalence of CHD remains high and increases during
ollow-up. Carcinoid heart disease progresses over time, highlight-
ng the need for echocardiographic follow-up once the diagnosis of
arcinoid syndrome is made.
oi:10.1016/j.acvd.2011.03.076
